Physician profile

David H Scates

Obstetrics & Gynecology · Roseville, CA

NPI 1477521235

$3,982.65

in general payments reported to CMS, 2019-2025

40 companies · $994 in 2025

The $994 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,824.04
Education$184.98

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astellas Pharma US INC $690.34 2020-2025 Veozah, Myrbetriq
Abbvie INC. $622.39 2019-2025 Orilissa, Lo Loestrin Fe
Hologic Sales and Service, LLC $293.95 2019-2025 Aptima, Coolseal Generator, Novasure
Daiichi Sankyo INC. $271.70 2021-2025 Injectafer
Sumitomo Pharma America, INC. $265.65 2023-2025 Myfembree
Sage Therapeutics, LLC $226.62 2024-2025 Zurzuvae
Pfizer INC. $162.11 2020-2025
Mayne Pharma Commercial LLC $140.02 2022-2025
Exact Sciences Corporation $124.78 2023-2025 Cologuard Collection Kit, The Cologuard Plus Collection Kit
Organon LLC $97.97 2023-2025 Nexplanon
Becton, Dickinson and Company $96.03 2024-2025 Hemosphere, Bd Onclarity
Ethicon US, LLC $81.30 2024-2025 Stratafix, Ethicon
Coopersurgical, INC. $79.43 2021-2023 Endosee
Therapeuticsmd, INC. $77.58 2019-2022
Neuronetics, INC. $65.00 2022
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Millicent US INC $59.58 2024-2025 Femring, Intrarosa
Merck Sharp & Dohme LLC $50.50 2019-2023 Gardasil 9
Agile Therapeutics, INC. $47.30 2023-2024 Twirla
Vertex Pharmaceuticals Incorporated $46.02 2025
Supernus Pharmaceuticals, INC. $41.50 2025 Qelbree
Medtronic, INC. $39.98 2021-2023 Truclear
Aspira Women'S Health INC $37.64 2022-2023 Ova1
Smith+Nephew, INC. $33.45 2025 Allevyn Heel 10.5cm X 13.5cm Ctn 5
Evofem Biosciences, INC. $33.13 2023-2025 Phexxi, Solosec, Phexx
Meditrina $30.60 2023-2024
Medline Industries LP $30.08 2024
Lsi Solutions INC $27.22 2024 Fornisee
Biohaven Pharmaceutical Holding Company LTD. $23.16 2022
Shield Therapeutics INC $19.71 2025
Vertical Pharmaceuticals, LLC $18.45 2019
Bayer Healthcare Pharmaceuticals INC. $17.81 2024
Amag Pharmaceuticals, INC. $17.36 2019
Solta Medical, A Division of Bausch Health US, LLC $16.70 2024
Convatec INC. $15.81 2023
Visby Medical, INC. $15.68 2022
Lilly USA, LLC $15.38 2024 Zepbound
Axonics, INC. $14.51 2022
Inspire Medical Systems, INC. $13.56 2023 Inspire
Allergan, INC. $12.41 2019
Channel Medsystems, INC. $10.24 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David H Scates

$3,982.65

in general payments reported 2019-2025

Years
2019-2025
Top company
Astellas Pharma US INC
Context
The $994 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

https://glasscript.com/doctor/21544/david-h-scates

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.